Home Newsletters Extracellular Matrix News Isoform Specific Anti-TGFβ Therapy Enhances Antitumor Efficacy in Mouse Models of Cancer

Isoform Specific Anti-TGFβ Therapy Enhances Antitumor Efficacy in Mouse Models of Cancer

0
Using B16 mouse melanoma and CT26 colon carcinoma as models of stroma-poor tumors, researchers demonstrated that myeloid/dendritic cells were the main sources of TGFβ1 and TGFβ3.
[Communications Biology]
7992332 {7992332:CCCCCCCC} apa 50 1 169060 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
Full Article
Exit mobile version